Review



recombinant human vegf rhvegf  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems recombinant human vegf rhvegf
    Recombinant Human Vegf Rhvegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegf rhvegf/product/R&D Systems
    Average 93 stars, based on 21 article reviews
    recombinant human vegf rhvegf - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    recombinant human vegf rhvegf  (R&D Systems)
    93
    R&D Systems recombinant human vegf rhvegf
    Recombinant Human Vegf Rhvegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegf rhvegf/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant human vegf rhvegf - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    rhvegf  (R&D Systems)
    96
    R&D Systems rhvegf
    Rhvegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rhvegf/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    rhvegf - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    rhvegf a isoforms  (R&D Systems)
    94
    R&D Systems rhvegf a isoforms
    Expression of CAP markers and VEGF-A <t>isoforms</t> during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .
    Rhvegf A Isoforms, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rhvegf a isoforms/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    rhvegf a isoforms - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    bt fgfb rhvegf r d systems  (R&D Systems)
    95
    R&D Systems bt fgfb rhvegf r d systems
    Expression of CAP markers and VEGF-A <t>isoforms</t> during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .
    Bt Fgfb Rhvegf R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bt fgfb rhvegf r d systems/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    bt fgfb rhvegf r d systems - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    rhvegf c  (R&D Systems)
    93
    R&D Systems rhvegf c
    Expression of CAP markers and VEGF-A <t>isoforms</t> during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .
    Rhvegf C, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rhvegf c/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    rhvegf c - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    recombinant human vegf165 rhvegf  (R&D Systems)
    96
    R&D Systems recombinant human vegf165 rhvegf
    Expression of CAP markers and VEGF-A <t>isoforms</t> during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .
    Recombinant Human Vegf165 Rhvegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegf165 rhvegf/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    recombinant human vegf165 rhvegf - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    rhvegf a165  (R&D Systems)
    96
    R&D Systems rhvegf a165
    Expression of CAP markers and VEGF-A <t>isoforms</t> during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .
    Rhvegf A165, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rhvegf a165/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    rhvegf a165 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    recombinant human vascular endothelial growth factor (rhvegf)  (PeproTech)
    90
    PeproTech recombinant human vascular endothelial growth factor (rhvegf)
    Expression of CAP markers and VEGF-A <t>isoforms</t> during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .
    Recombinant Human Vascular Endothelial Growth Factor (Rhvegf), supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vascular endothelial growth factor (rhvegf)/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant human vascular endothelial growth factor (rhvegf) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of CAP markers and VEGF-A isoforms during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung development

    doi: 10.3389/fcell.2025.1729884

    Figure Lengend Snippet: Expression of CAP markers and VEGF-A isoforms during human prenatal lung development. RT-qPCR analysis of the expression of universal capillary marker CA4 and CAP2 specific markers ( SOSTDC1 , HPGD, EDNRB, CA4, APLN, and TBX2 ) (A) and of total VEGF-A ( VEGF-Atot ) as well as each VEGF-A isoform ( VEGF-A121 , VEGF-A145 , VEGF-A165 , VEGF-A189 ) (B) in native human prenatal lungs aged from the late pseudoglandular to the early canalicular stages of development (week 10–20 of GA). Results are shown as a dot plot with mean ± SEM, n = 8–10, * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Visual summary of the VEGF-A isoforms and CAP2 markers expression during human prenatal lung development. Image created by Biorender.com .

    Article Snippet: The rhVEGF-A isoforms come from R&D system (VEGF-A121: cat#4644-VS-010, VEGF-A145: cat#7626-VE-010, VEGF-A165: cat#293-VE-010, VEGF-A189: cat#8147-VE-025).

    Techniques: Expressing, Quantitative RT-PCR, Marker

    Effect of VEGF-A isoforms on human prenatal lung explant morphology. Representative pictures of the human prenatal lung explant cultures, either untreated or treated with the different VEGF-A isoforms alone or in combinations (VEGF-A121, VEGF-A145, VEGF-A165, VEGF-A189, VEGF-A121-145, and VEGF-A121-145–189) for 48 h. Photos were taken at time 0 (left, (A) and at 48 h (right, (B) . At 48 h, hematoxylin-eosin staining was performed to evaluate the histology of the explants (C) . Scale bar indicated by 50 µm.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung development

    doi: 10.3389/fcell.2025.1729884

    Figure Lengend Snippet: Effect of VEGF-A isoforms on human prenatal lung explant morphology. Representative pictures of the human prenatal lung explant cultures, either untreated or treated with the different VEGF-A isoforms alone or in combinations (VEGF-A121, VEGF-A145, VEGF-A165, VEGF-A189, VEGF-A121-145, and VEGF-A121-145–189) for 48 h. Photos were taken at time 0 (left, (A) and at 48 h (right, (B) . At 48 h, hematoxylin-eosin staining was performed to evaluate the histology of the explants (C) . Scale bar indicated by 50 µm.

    Article Snippet: The rhVEGF-A isoforms come from R&D system (VEGF-A121: cat#4644-VS-010, VEGF-A145: cat#7626-VE-010, VEGF-A165: cat#293-VE-010, VEGF-A189: cat#8147-VE-025).

    Techniques: Staining

    Impact of VEGF-A isoforms on endothelial cell proliferation in human prenatal lung explants. (A–G) Representative pictures of human prenatal lung explants, aged from the late pseudoglandular to the early canalicular stage (16–21 weeks of GA), untreated (A) or treated with VEGF-A121 (B) , VEGF-A145 (C) , VEGF-A165 (D) , VEGF-A189 (E) , VEGF-A121-145 (F) or VEGF-A121-145-189 (G) for 48 h, stained for CD31 (red) and Ki67 (green) by IF. Nuclei were counterstained with DAPI (blue). (H,I) Associated quantification of the number of CD31-positive cells (H) and the percentage of Ki67-CD31double-positive cells (I) . Results are shown as a dot plot with mean ± SEM, n = 3–9. Scale bar indicated by 50 µm.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung development

    doi: 10.3389/fcell.2025.1729884

    Figure Lengend Snippet: Impact of VEGF-A isoforms on endothelial cell proliferation in human prenatal lung explants. (A–G) Representative pictures of human prenatal lung explants, aged from the late pseudoglandular to the early canalicular stage (16–21 weeks of GA), untreated (A) or treated with VEGF-A121 (B) , VEGF-A145 (C) , VEGF-A165 (D) , VEGF-A189 (E) , VEGF-A121-145 (F) or VEGF-A121-145-189 (G) for 48 h, stained for CD31 (red) and Ki67 (green) by IF. Nuclei were counterstained with DAPI (blue). (H,I) Associated quantification of the number of CD31-positive cells (H) and the percentage of Ki67-CD31double-positive cells (I) . Results are shown as a dot plot with mean ± SEM, n = 3–9. Scale bar indicated by 50 µm.

    Article Snippet: The rhVEGF-A isoforms come from R&D system (VEGF-A121: cat#4644-VS-010, VEGF-A145: cat#7626-VE-010, VEGF-A165: cat#293-VE-010, VEGF-A189: cat#8147-VE-025).

    Techniques: Staining

    Impact of VEGF-A isoforms on the expression of CAP2 markers in human prenatal lung explants. RT-qPCR analysis of the expression of CAP2 markers ( HPGD , EDNRB , CA4, and APLN ) in human prenatal lung explants aged from the late pseudoglandular to the early canalicular stage (16–21 weeks of GA), untreated or treated with the different VEGF-A isoforms alone or in combinations (VEGF-A121, VEGF-A145, VEGF-A165, VEGF-A189, VEGF-A121-145, and VEGF-A121-145–189) for 48 h. Results are shown as a dot plot with mean ± SEM, n = 4–15, * p < 0.05, ** p < 0.01.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung development

    doi: 10.3389/fcell.2025.1729884

    Figure Lengend Snippet: Impact of VEGF-A isoforms on the expression of CAP2 markers in human prenatal lung explants. RT-qPCR analysis of the expression of CAP2 markers ( HPGD , EDNRB , CA4, and APLN ) in human prenatal lung explants aged from the late pseudoglandular to the early canalicular stage (16–21 weeks of GA), untreated or treated with the different VEGF-A isoforms alone or in combinations (VEGF-A121, VEGF-A145, VEGF-A165, VEGF-A189, VEGF-A121-145, and VEGF-A121-145–189) for 48 h. Results are shown as a dot plot with mean ± SEM, n = 4–15, * p < 0.05, ** p < 0.01.

    Article Snippet: The rhVEGF-A isoforms come from R&D system (VEGF-A121: cat#4644-VS-010, VEGF-A145: cat#7626-VE-010, VEGF-A165: cat#293-VE-010, VEGF-A189: cat#8147-VE-025).

    Techniques: Expressing, Quantitative RT-PCR

    VEGF-A isoforms induce APLN expression in endothelial cells. (A–G) Representative pictures of human prenatal lung explants, aged from the late pseudoglandular to the early canalicular stage (16–21 weeks of GA), untreated (A) or treated with VEGF-A121 (B) , VEGF-A145 (C) , VEGF-A165 (D) , VEGF-A189 (E) , VEGF-A121-145 (F) or VEGF-A121-145-189 (G) for 48 h, stained for CD31 (green) and Claudin-5 (white) by IF, and for APLN (red) by FISH. Nuclei were counterstained with DAPI (blue). (H,I) Associated quantification of the percentage of APLN + cells (H) and the percentage of APLN + CD31 + CLDN5+ cells (I) . Results are shown as a dot plot with mean ± SEM, n = 4, * p < 0.05, ** p < 0.01. Scale bar indicated by 50 µm.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: VEGF-A isoforms induce the expression of APLN in endothelial cells during human prenatal lung development

    doi: 10.3389/fcell.2025.1729884

    Figure Lengend Snippet: VEGF-A isoforms induce APLN expression in endothelial cells. (A–G) Representative pictures of human prenatal lung explants, aged from the late pseudoglandular to the early canalicular stage (16–21 weeks of GA), untreated (A) or treated with VEGF-A121 (B) , VEGF-A145 (C) , VEGF-A165 (D) , VEGF-A189 (E) , VEGF-A121-145 (F) or VEGF-A121-145-189 (G) for 48 h, stained for CD31 (green) and Claudin-5 (white) by IF, and for APLN (red) by FISH. Nuclei were counterstained with DAPI (blue). (H,I) Associated quantification of the percentage of APLN + cells (H) and the percentage of APLN + CD31 + CLDN5+ cells (I) . Results are shown as a dot plot with mean ± SEM, n = 4, * p < 0.05, ** p < 0.01. Scale bar indicated by 50 µm.

    Article Snippet: The rhVEGF-A isoforms come from R&D system (VEGF-A121: cat#4644-VS-010, VEGF-A145: cat#7626-VE-010, VEGF-A165: cat#293-VE-010, VEGF-A189: cat#8147-VE-025).

    Techniques: Expressing, Staining